These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 15679806

  • 1. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition.
    Kausch I, Jiang H, Ewerdwalbesloh N, Doehn C, Krüger S, Sczakiel G, Jocham D.
    BJU Int; 2005 Feb; 95(3):416-20. PubMed ID: 15679806
    [Abstract] [Full Text] [Related]

  • 2. [Ki-67 antisense therapy in murine renal cell carcinoma models].
    Kausch I, Jiang H, Brocks C, Albers A, Krüger S, Sczakiel G, Jocham D.
    Aktuelle Urol; 2005 Apr; 36(2):142-8. PubMed ID: 15902575
    [Abstract] [Full Text] [Related]

  • 3. Ki-67-directed antisense therapy in an orthotopic renal cell carcinoma model.
    Kausch I, Jiang H, Brocks C, Bruderek K, Krüger S, Sczakiel G, Jocham D, Böhle A.
    Eur Urol; 2004 Jul; 46(1):118-24; discussion 124-5. PubMed ID: 15183557
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
    Kausch I, Jiang H, Thode B, Doehn C, Krüger S, Jocham D.
    Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
    [Abstract] [Full Text] [Related]

  • 5. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
    Weber KL, Doucet M, Price JE, Baker C, Kim SJ, Fidler IJ.
    Cancer Res; 2003 Jun 01; 63(11):2940-7. PubMed ID: 12782601
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
    Yildiz E, Gokce G, Kilicarslan H, Ayan S, Goze OF, Gultekin EY.
    BJU Int; 2004 May 01; 93(7):1087-93. PubMed ID: 15142169
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of nuclear factor kappa B attenuates tumour progression in an animal model of renal cell carcinoma.
    Morais C, Healy H, Johnson DW, Gobe G.
    Nephrol Dial Transplant; 2010 May 01; 25(5):1462-74. PubMed ID: 20037166
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM, Thijssen VL, Van den Eynden GG, Van Laere SJ, Bluekens AM, Roskams T, van Poppel H, De Bruïne AP, Griffioen AW, Vermeulen PB.
    Br J Cancer; 2007 Jun 18; 96(12):1888-95. PubMed ID: 17505508
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Knockdown of Ki-67 by small interfering RNA leads to inhibition of proliferation and induction of apoptosis in human renal carcinoma cells.
    Zheng JN, Ma TX, Cao JY, Sun XQ, Chen JC, Li W, Wen RM, Sun YF, Pei DS.
    Life Sci; 2006 Jan 11; 78(7):724-9. PubMed ID: 16111722
    [Abstract] [Full Text] [Related]

  • 13. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides.
    Gnarra JR, Dressler GR.
    Cancer Res; 1995 Sep 15; 55(18):4092-8. PubMed ID: 7664285
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.
    Acta Pharmacol Sin; 2005 Jun 15; 26(6):753-61. PubMed ID: 15916743
    [Abstract] [Full Text] [Related]

  • 16. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
    Matsuyama M, Yoshimura R, Mitsuhashi M, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T.
    Oncol Rep; 2005 Jul 15; 14(1):73-9. PubMed ID: 15944770
    [Abstract] [Full Text] [Related]

  • 17. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
    Prewett M, Rothman M, Waksal H, Feldman M, Bander NH, Hicklin DJ.
    Clin Cancer Res; 1998 Dec 15; 4(12):2957-66. PubMed ID: 9865906
    [Abstract] [Full Text] [Related]

  • 18. Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma.
    Nakanishi H, Mizutani Y, Kawauchi A, Ukimura O, Shiraishi T, Hatano M, Mizuno M, Yoshida J, Miki T.
    Clin Cancer Res; 2003 Mar 15; 9(3):1129-35. PubMed ID: 12631618
    [Abstract] [Full Text] [Related]

  • 19. Bone resorption and renal calcium reabsorption in renal cell carcinoma-bearing mice: the effects of bisphosphonate.
    Weissglas M, Löwik C, Schamhart D, Theuns H, Kurth KH, Papapoulos S.
    BJU Int; 2007 Jun 15; 99(6):1530-3. PubMed ID: 17428243
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.
    Plonowski A, Schally AV, Nagy A, Kiaris H, Hebert F, Halmos G.
    Cancer Res; 2000 Jun 01; 60(11):2996-3001. PubMed ID: 10850448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.